by Michael Nevradakis, Ph.D., Childrens Health Defense:

The U.S. Food and Drug Administration said the new vaccines are “formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death.” However, the vaccines target the XBB.1.5 variant, which “is declining in the U.S.,” according to CNBC.

The U.S. Food and Drug Administration (FDA) on Monday approved updated mRNA COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, paving the way for their approval by the Centers for Disease Control and Prevention (CDC).